{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:13:12Z","timestamp":1696018392147},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s40271-013-0021-4","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T07:45:37Z","timestamp":1375688737000},"page":"225-231","source":"Crossref","is-referenced-by-count":5,"title":["Demonstrating Measurement Equivalence of the Electronic and Paper Formats of the Urticaria Patient Daily Diary in Patients with Chronic Idiopathic Urticaria"],"prefix":"10.1007","volume":"6","author":[{"given":"Emuella M.","family":"Flood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Zazzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Devlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"issue":"1","key":"21_CR1","first-page":"31","volume":"3","author":"M Ferrer","year":"2007","unstructured":"Ferrer M, Kaplan AP. Progress and challenges in the understanding of chronic urticaria. Allergy Asthma Clin Immunol. 2007;3(1):31\u20135.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"21_CR2","first-page":"9","volume":"2","author":"G Lorenzo Di","year":"2009","unstructured":"Di Lorenzo G, D\u2019Alcamo A, Rizzo M, et al. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. J Asthma Allergy. 2009;2:9\u201316.","journal-title":"J Asthma Allergy"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1398-9995.2005.00964.x","volume":"61","author":"T Zuberier","year":"2006","unstructured":"Zuberier T, Bindslev-Jensen C, Canonica W, et al. EAACI\/GA2LEN\/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006;61:316\u201320.","journal-title":"Allergy"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","volume":"63","author":"A Mlynek","year":"2008","unstructured":"Mlynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63:777\u201380.","journal-title":"Allergy"},{"issue":"4","key":"21_CR5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09546630802607495","volume":"20","author":"KS Wan","year":"2009","unstructured":"Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J Dermatol Treat. 2009;20(4):194\u20137.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"21_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","volume":"122","author":"AP Kaplan","year":"2008","unstructured":"Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122(3):569\u201373.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"21_CR7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1346-8138.2008.00466.x","volume":"35","author":"H Serhat Inaloz","year":"2008","unstructured":"Serhat Inaloz H, Ozturk S, Akcali C, et al. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J Dermatol. 2008;35(5):276\u201382.","journal-title":"J Dermatol"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anai.2010.06.011","volume":"105","author":"SD Mathias","year":"2010","unstructured":"Mathias SD, Dreskin SC, Kaplan A, et al. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010;105:142\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"21_CR9","unstructured":"US Department of Health and Human Services Food and Drug Administration FDA Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims; 2009. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf ."},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2500\/aap.2012.33.3508","volume":"33","author":"SD Mathias","year":"2012","unstructured":"Mathias SD, Tschosik EA, Zazzali JL. Adaptation and validation of the Urticaria Patient Daily Diary for adolescents. Allergy Asthma Proc. 2012;33:186\u201390.","journal-title":"Allergy Asthma Proc"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.anai.2011.09.008","volume":"108","author":"SD Mathias","year":"2012","unstructured":"Mathias SD, Crosby RD, Zazzali JL, et al. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108:20\u20134.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"21_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/014662168100500114","volume":"5","author":"DV Cicchetti","year":"1981","unstructured":"Cicchetti DV. Testing the normal approximation and minimal sample size requirements of weighted kappa when the number of categories is large. App Psychol Meas. 1981;5(1):101\u20134.","journal-title":"App Psychol Meas"},{"issue":"2","key":"21_CR13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1524-4733.2007.00231.x","volume":"11","author":"CJ Gwaltney","year":"2008","unstructured":"Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008;11(2):322\u201333.","journal-title":"Value Health"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/h0026256","volume":"70","author":"J Cohen","year":"1968","unstructured":"Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213\u201320.","journal-title":"Psychol Bull"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/001316447303300309","volume":"33","author":"JL Fleiss","year":"1973","unstructured":"Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613\u20139.","journal-title":"Educ Psychol Meas"},{"issue":"4","key":"21_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1524-4733.2008.00470.x","volume":"12","author":"SJ Coons","year":"2009","unstructured":"Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value Health. 2009;12(4):419\u201329.","journal-title":"Value Health"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420\u20138.","journal-title":"Psychol Bull"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-013-0021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40271-013-0021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-013-0021-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:38Z","timestamp":1559490278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40271-013-0021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s40271-013-0021-4","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,6]]}}}